Loading…
Loading…
CPTN (Cepton, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
CPTN does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CPTN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CPTN and 80,000+ other tickers.
See exactly how CPTN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CPTN and 80,000+ other tickers.
Cepton, Inc. specializes in developing and distributing cutting-edge lidar technology for various sectors globally, encompassing automotive, smart cities, intelligent spaces, and industrial applications across the United States, Japan, and other international markets. The company's product portfolio includes a range of auto-grade lidar sensors. For long-distance sensing, the Vista-X is a compact option with a detection range of up to 200 meters, making it suitable for advanced driver-assistance systems (ADAS L2+/L3), autonomous vehicles (AV L4/L5), and smart infrastructure. Pushing the…
NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ: CPTN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or sold shares of Cepton common stock between July 29, 2024 and January 6, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
LOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cepton, Inc., (“Cepton” or the "Company") (NASDAQ: CPTN) investors of a class action on behalf of investors that bought securities between July 29, 2024 and January 6, 2025, inclusive (the “Class Period”). Cepton investors have until December 8, 2025 to file a lead plaintiff motion.
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cepton, Inc. (“Cepton” or “the Company”) (NASDAQ: CPTN) and certain of its officers.
New York, New York--(Newsfile Corp. - December 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
The complaint alleges Cepton hid a higher bid, failed to evaluate or disclose it, depriving shareholders of a fair choice and making statements misleading.